File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN

TitleRapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN
Authors
Issue Date2013
Citation
Experimental and Molecular Pathology, 2013, v. 94 n. 1, p. 255-261 How to Cite?
AbstractHIV-associated nephropathy (HIVAN) is the manifestation of HIV gene expression by kidney cells in the presence of specific host factors. Recently, rapamycin (sirolimus) has been demonstrated to modulate the progression of HIVAN. We hypothesized that rapamycin would modulate the progression of HIVAN by attenuating HIV gene expression. To test our hypothesis, three weeks old Tg26 mice (n. =. 6) were administered either vehicle or rapamycin (5. mg/kg, every other day, intraperitoneal) for eight weeks. At the end of the experimental period, the kidneys were harvested. In in vitro studies, human podocytes were transduced with either HIV-1 (NL4-3) or empty vector (EV), followed by treatment with either vehicle or rapamycin. Total RNA and proteins were extracted from renal tissues/cellular lysates and HIV gene transcription/translation was measured by real time PCR and Western blotting studies. Renal histological slides were graded for glomerular sclerosis and tubular dilatation with microcyst formation. Rapamycin attenuated both glomerular and tubular lesions in Tg26 mice. Rapamycin decreased transcription of HIV genes both in renal tissues as well as in HIV-1 transduced podocytes. Our data strongly indicate that HIV-1 long terminal repeat-mediated transcriptional activity was targeted by rapamycin. Rapamycin enhanced podocyte NF-κB and CREB activities but then it decreased AP-1 binding activity. Since expression of HIV genes by kidney cells has been demonstrated to be the key factor in the development HIVAN, it appears that rapamycin-induced altered transcription of HIV genes might have partly contributed to its disease modulating effects. © 2012 Elsevier Inc.
Persistent Identifierhttp://hdl.handle.net/10722/195398
ISSN
2015 Impact Factor: 2.638
2015 SCImago Journal Rankings: 1.130
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRai, P-
dc.contributor.authorPlagov, A-
dc.contributor.authorKumar, D-
dc.contributor.authorPathak, S-
dc.contributor.authorAyasolla, KR-
dc.contributor.authorChawla, AK-
dc.contributor.authorMathieson, PW-
dc.contributor.authorSaleem, MA-
dc.contributor.authorHusain, M-
dc.contributor.authorMalhotra, A-
dc.contributor.authorSinghal, PC-
dc.date.accessioned2014-02-28T06:12:05Z-
dc.date.available2014-02-28T06:12:05Z-
dc.date.issued2013-
dc.identifier.citationExperimental and Molecular Pathology, 2013, v. 94 n. 1, p. 255-261-
dc.identifier.issn0014-4800-
dc.identifier.urihttp://hdl.handle.net/10722/195398-
dc.description.abstractHIV-associated nephropathy (HIVAN) is the manifestation of HIV gene expression by kidney cells in the presence of specific host factors. Recently, rapamycin (sirolimus) has been demonstrated to modulate the progression of HIVAN. We hypothesized that rapamycin would modulate the progression of HIVAN by attenuating HIV gene expression. To test our hypothesis, three weeks old Tg26 mice (n. =. 6) were administered either vehicle or rapamycin (5. mg/kg, every other day, intraperitoneal) for eight weeks. At the end of the experimental period, the kidneys were harvested. In in vitro studies, human podocytes were transduced with either HIV-1 (NL4-3) or empty vector (EV), followed by treatment with either vehicle or rapamycin. Total RNA and proteins were extracted from renal tissues/cellular lysates and HIV gene transcription/translation was measured by real time PCR and Western blotting studies. Renal histological slides were graded for glomerular sclerosis and tubular dilatation with microcyst formation. Rapamycin attenuated both glomerular and tubular lesions in Tg26 mice. Rapamycin decreased transcription of HIV genes both in renal tissues as well as in HIV-1 transduced podocytes. Our data strongly indicate that HIV-1 long terminal repeat-mediated transcriptional activity was targeted by rapamycin. Rapamycin enhanced podocyte NF-κB and CREB activities but then it decreased AP-1 binding activity. Since expression of HIV genes by kidney cells has been demonstrated to be the key factor in the development HIVAN, it appears that rapamycin-induced altered transcription of HIV genes might have partly contributed to its disease modulating effects. © 2012 Elsevier Inc.-
dc.languageeng-
dc.relation.ispartofExperimental and Molecular Pathology-
dc.titleRapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.yexmp.2012.09.009-
dc.identifier.pmid23010541-
dc.identifier.scopuseid_2-s2.0-84871410323-
dc.identifier.volume94-
dc.identifier.issue1-
dc.identifier.spage255-
dc.identifier.epage261-
dc.identifier.isiWOS:000315006500037-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats